Literature DB >> 8735714

Genetic pathways in colorectal cancer.

M Ilyas1, I P Tomlinson.   

Abstract

The model of colorectal tumorigenesis put forward by Fearon and Vogelstein has had great influence on molecular oncology. They proposed that a series of mutations occur in the progression from normal cells to colorectal cancer and that these mutations are associated with the histological features of such tumours. Several postulates of the model appear to be correct, particularly its emphasis on the stepwise accumulation of genetic changes and the inclusion of mutations at the adenomatous polyposis coli (APC) and TP53 loci. Since the publication of the original model, however, mutations at other loci have been identified which may be alternatives or additions. There is also evidence to suggest that some colorectal cancers develop along a different genetic pathway. In this review, we discuss how tumour development can occur as Darwinian evolution through selection of advantageous somatic mutations. The non-random nature of mutation selection gives rise to genetic pathways of tumorigenesis. In addition, we consider the Fearon and Vogelstein model, its shortcomings and possible additions to it. The evidence suggests that not all colorectal cancers follow the same genetic pathway during carcinogenesis.

Entities:  

Mesh:

Year:  1996        PMID: 8735714     DOI: 10.1046/j.1365-2559.1996.339381.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  16 in total

Review 1.  The clonal origin and clonal evolution of epithelial tumours.

Authors:  S B Garcia; M Novelli; N A Wright
Journal:  Int J Exp Pathol       Date:  2000-04       Impact factor: 1.925

2.  Genetic lesions during progression of hereditary non-polypous colorectal cancer.

Authors:  T A Shtam; O A Vostryukhina; A V Gulyaev; K M Pozharissky; V A Lantsov
Journal:  Dokl Biochem Biophys       Date:  2004 Mar-Apr       Impact factor: 0.788

Review 3.  What we could do now: molecular pathology of colorectal cancer.

Authors:  R S Houlston
Journal:  Mol Pathol       Date:  2001-08

4.  Expression of p53, p21/waf, bcl-2, bax, Rb and Ki67 proteins in colorectal adenocarcinomas.

Authors:  P Kanavaros; K Stefanaki; K Valassiadou; J Vlachonikolis; M Mavromanolakis; M Vlychou; S Kakolyris; V Gorgoulis; M Tzardi; V Georgoulias
Journal:  Med Oncol       Date:  1999-04       Impact factor: 3.064

Review 5.  Evolving notions on immune response in colorectal cancer and their implications for biomarker development.

Authors:  Fabio Grizzi; Gianluca Basso; Elena Monica Borroni; Tommaso Cavalleri; Paolo Bianchi; Sanja Stifter; Maurizio Chiriva-Internati; Alberto Malesci; Luigi Laghi
Journal:  Inflamm Res       Date:  2018-01-10       Impact factor: 4.575

6.  Genetic alterations and epithelial dysplasia in juvenile polyposis syndrome and sporadic juvenile polyps.

Authors:  T T Wu; B Rezai; A Rashid; M C Luce; M C Cayouette; C Kim; N Sani; L Mishra; C A Moskaluk; J H Yardley; S R Hamilton
Journal:  Am J Pathol       Date:  1997-03       Impact factor: 4.307

7.  p53 and K-ras gene mutations in carcinoma of the rectum among Finnish women.

Authors:  K Servomaa; A Kiuru; V M Kosma; P Hirvikoski; T Rytömaa
Journal:  Mol Pathol       Date:  2000-02

8.  Progression from colorectal adenoma to carcinoma is associated with non-random chromosomal gains as detected by comparative genomic hybridisation.

Authors:  G A Meijer; M A Hermsen; J P Baak; P J van Diest; S G Meuwissen; J A Beliën; J M Hoovers; H Joenje; P J Snijders; J M Walboomers
Journal:  J Clin Pathol       Date:  1998-12       Impact factor: 3.411

9.  Infrequent K-ras codon 12 mutation in serrated adenomas of human colorectum.

Authors:  Y Ajioka; H Watanabe; J R Jass; Y Yokota; M Kobayashi; K Nishikura
Journal:  Gut       Date:  1998-05       Impact factor: 23.059

10.  Clinical and molecular biologic characteristics of early-onset versus late-onset colorectal carcinoma in Filipinos.

Authors:  Gemma B Uy; Leoncio L Kaw; Corazon K Punzalan; R Ireneo Luis C Querol; Elena V Koustova; Mark W Bowyer; Christine M Hobbs; Leslie H Sobin; David C Wherry
Journal:  World J Surg       Date:  2004-01-08       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.